Loading clinical trials...
Loading clinical trials...
Full-spectrum Medical Canabis Product (HemPhar) With a CBD:THC Ratio of 10:1 for Treatment of Spasticity in Children and Young Adults With Severe Forms of Cerebral Palsy
Conditions
Interventions
Lab tests
ECG
+7 more
Locations
2
Slovenia
PharmaHemp
Ljubljana, Slovenia
University Medical Centre Ljubljana
Ljubljana, Slovenia
Start Date
October 15, 2020
Primary Completion Date
December 1, 2023
Completion Date
February 29, 2024
Last Updated
May 22, 2024
NCT05883540
NCT07546435
NCT06395558
NCT07123298
NCT06326905
NCT07444697
Lead Sponsor
University Medical Centre Ljubljana
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions